Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 148594, 12 pages
http://dx.doi.org/10.1155/2014/148594
Research Article

Commercial Bovine Proteoglycan Is Highly Arthritogenic and Can Be Used as an Alternative Antigen Source for PGIA Model

Department of Microbiology and Immunology, Biosciences Institute, São Paulo State University (UNESP), 18618-000 Botucatu, SP, Brazil

Received 28 February 2014; Revised 29 April 2014; Accepted 1 May 2014; Published 27 May 2014

Academic Editor: Yehuda Shoenfeld

Copyright © 2014 Larissa Lumi Watanabe Ishikawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO Scientific Group, “The burden of musculoskeletal conditions at the start of the new millennium,” Technical Repors 919, World Health Organization, Geneva, Switzerland, 2003. View at Google Scholar
  2. J. B. Imboden, “The immunopathogenesis of rheumatoid arthritis,” Annual Review of Pathology: Mechanisms of Disease, vol. 4, pp. 417–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. W. Song and E. H. Kang, “Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies,” QJM, vol. 103, no. 3, Article ID hcp165, pp. 139–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Gizinski and D. A. Fox, “T cell subsets and their role in the pathogenesis of rheumatic disease,” Current Opinion in Rheumatology, vol. 26, no. 2, pp. 204–210, 2014. View at Publisher · View at Google Scholar
  5. Z. Szekanecz and A. E. Koch, “Macrophages and their products in rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 19, no. 3, pp. 289–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Choy, “Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis,” Rheumatology, vol. 51, no. 5, Article ID kes113, pp. 3–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. I. Koenders and W. B. Van Den Berg, “Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?” Clinical and Experimental Immunology, vol. 159, no. 2, pp. 131–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Nakken, L. A. Munthe, Y. T. Konttinen et al., “B-cells and their targeting in rheumatoid arthritis—current concepts and future perspectives,” Autoimmunity Reviews, vol. 11, no. 1, pp. 28–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Oh, A. L. Rankin, and A. J. Caton, “CD4+CD25+ regulatory T cells in autoimmune arthritis,” Immunological Reviews, vol. 233, no. 1, pp. 97–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. H. Wooley, J. R. Seibold, J. D. Whalen, and J. M. Chapdelaine, “Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease,” Arthritis and Rheumatism, vol. 32, no. 8, pp. 1022–1030, 1989. View at Google Scholar · View at Scopus
  11. C. Vingsbo-Lundberg, N. Nordquist, P. Olofsson et al., “Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats,” Nature Genetics, vol. 20, no. 4, pp. 401–404, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Brenner, T. Laragione, and P. S. Gulko, “Arthritis severity locus Cia4 is an early regulator of IL-6, IL-1β, and NF-κB activators' expression in pristane-induced arthritis,” Physiological Genomics, vol. 45, no. 13, pp. 552–564, 2013. View at Google Scholar
  13. T. T. Glant, A. Finnegan, and K. Mikecz, “Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics,” Critical Reviews in Immunology, vol. 23, no. 3, pp. 199–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. D. D. Brand, A. H. Kang, and E. F. Rosloniec, “Immunopathogenesis of collagen arthritis,” Springer Seminars in Immunopathology, vol. 25, no. 1, pp. 3–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Keffer, L. Probert, H. Cazlaris et al., “Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis,” EMBO Journal, vol. 10, no. 13, pp. 4025–4031, 1991. View at Google Scholar · View at Scopus
  16. X. Zhu, L. Xiao, R. Huo et al., “Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 15, no. 6, p. R187, 2013. View at Publisher · View at Google Scholar
  17. C. H. Sarithakumari and G. M. Kurup, “Alginic acid isolated from Sargassumwightii exhibits anti-inflammatory potential on type II collagen induced arthritis in experimental animals,” International Immunopharmacology, vol. 17, no. 4, pp. 1108–1115, 2013. View at Google Scholar
  18. J. Woo, M. P. Vierboom, H. Kwon et al., “PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis,” Arthritis Research & Therapy, vol. 15, no. 6, p. R207, 2013. View at Google Scholar
  19. T. Eneljung, S. Tengvall, P. Jirholt et al., “Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis,” Clinical and Developmental Immunology, vol. 2013, Article ID 345092, 11 pages, 2013. View at Publisher · View at Google Scholar
  20. E. I. Buzás, A. Végvári, Y. M. Murad, A. Finnegan, K. Mikecz, and T. T. Glant, “T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis,” Cellular Immunology, vol. 235, no. 2, pp. 98–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. P. D. Doodes, Y. Cao, K. M. Hamel et al., “IFN-γ regulates the requirement for IL-17 in proteoglycan-induced arthritis,” Journal of Immunology, vol. 184, no. 3, pp. 1552–1559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Finnegan, M. J. Grusby, C. D. Kaplan et al., “IL-4 and IL-12 regulate proteoglycan-induced arthritis through stat-dependent mechanisms,” Journal of Immunology, vol. 169, no. 6, pp. 3345–3352, 2002. View at Google Scholar · View at Scopus
  23. A. Hanyecz, S. E. Berlo, S. Szántó, C. P. M. Broeren, K. Mikecz, and T. T. Glant, “Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype,” Arthritis and Rheumatism, vol. 50, no. 5, pp. 1665–1676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. W. B. van den Berg, “Lessons from animal models of arthritis over the past decade,” Arthritis Research and Therapy, vol. 11, no. 5, p. 250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. T. T. Glant and K. Mikecz, “Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis,” Methods in Molecular Medicine, vol. 102, pp. 313–338, 2004. View at Google Scholar · View at Scopus
  26. T. Besenyei, A. Kadar, B. Tryniszewska et al., “Non-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models,” Clinical and Developmental Immunology, vol. 2012, Article ID 284751, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Y. Leroux, A. Guerassimov, A. Cartman et al., “Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo,” The Journal of Clinical Investigation, vol. 97, no. 3, pp. 621–632, 1996. View at Google Scholar
  28. R. C. Jeffery, “Clinical features of rheumatoid arthritis,” Medicine, vol. 38, no. 4, pp. 167–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Tarjanyi, F. Boldizsar, P. Nemeth, K. Mikecz, and T. T. Glant, “Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis,” Immunity and Ageing, vol. 11, no. 6, p. 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Walcz, F. Deak, P. Erhardt et al., “Complete coding sequence, deduced primary structure, chromosomal localization, and structural analysis of murine aggrecan,” Genomics, vol. 22, no. 2, pp. 364–371, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Holló, T. T. Glant, M. Garzó, A. Finnegan, K. Mikecz, and E. Buzás, “Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis,” Clinical and Experimental Immunology, vol. 120, no. 1, pp. 167–173, 2000. View at Google Scholar · View at Scopus
  32. T. T. Glant, M. Radacs, G. Nagyeri et al., “Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 63, no. 5, pp. 1312–1321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Tham, S. Ramasamy, H. T. Gan et al., “CSPG is a secreted factor that stimulates neural stem cell survival possibly by enhanced EGFR signaling,” PLoS ONE, vol. 5, no. 12, Article ID e15341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. C. A. Antonopoulos, I. Axelsson, D. Heinegard, and S. Gardell, “Extraction and purification of proteoglycans from various types of connective tissue,” Biochimica et Biophysica Acta, vol. 338, no. 1, pp. 108–119, 1974. View at Google Scholar · View at Scopus
  35. Y. Zhang, A. Guerassimov, J. Leroux et al., “Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes,” American Journal of Pathology, vol. 153, no. 4, pp. 1283–1291, 1998. View at Google Scholar · View at Scopus
  36. J. Chen, H. Wu, Q. Wang et al., “Ginsenoside metabolite compound K alleviates adjuvant-induced arthritis by suppressing T cell activation,” Inflammation, 2014. View at Google Scholar
  37. A. Poosarla, R. DN, R. R. Athota, and V. G. Sunkara, “Modulation of T cell proliferation and cytokine response by Plumbagin, extracted from Plumbago zeylanica in collagen induced arthritis,” BMC Complementary and Alternative Medicine, vol. 11, p. 114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. H. G. Schaible, G. S. von Banchet, M. K. Boettger et al., “The role of proinflammatory cytokines in the generation and maintenance of joint pain: annals of the New York Academy of Sciences,” Annals of the New York Academy of Sciences, vol. 1193, pp. 60–69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. L. Scott, “Biologics-based therapy for the treatment of rheumatoid arthritis,” Clinical Pharmacology and Therapeutics, vol. 91, no. 1, pp. 30–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Chabaud, P. Garnero, J. Dayer, P. Guerne, F. Fossiez, and P. Miossec, “Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis,” Cytokine, vol. 12, no. 7, pp. 1092–1099, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Lubberts, P. Schwarzenberger, W. Huang et al., “Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis,” Journal of Immunology, vol. 175, no. 5, pp. 3360–3368, 2005. View at Google Scholar · View at Scopus
  42. M. E. Truchetet, M. D. Mossalayi, and K. Boniface, “IL-17 in the rheumatologist's line of sight,” Biomed Research International, vol. 2013, Article ID 295132, 18 pages, 2013. View at Publisher · View at Google Scholar
  43. E. Lubberts, M. I. Koenders, B. Oppers-Walgreen et al., “Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion,” Arthritis and Rheumatism, vol. 50, no. 2, pp. 650–659, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. K. A. Bush, K. M. Farmer, J. S. Walker, and B. W. Kirkham, “Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein,” Arthritis and Rheumatism, vol. 46, no. 3, pp. 802–805, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Alzabin and R. O. Williams, “Effector T cells in rheumatoid arthritis: lessons from animal models,” FEBS Letters, vol. 585, no. 23, pp. 3649–3659, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Lee, J. Lee, M. Park et al., “Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase,” PLoS ONE, vol. 8, no. 4, Article ID e60900, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Kaplan, J. C. Valdez, R. Chandrasekaran et al., “Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis,” Arthritis Research, vol. 4, no. 1, pp. 54–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. J. A. van Roon, C. M. Verhoef, J. L. van Roy et al., “Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease,” Annals of the Rheumatic Diseases, vol. 56, no. 11, pp. 656–660, 1997. View at Publisher · View at Google Scholar
  49. R. Gerli, O. Bistoni, A. Russano et al., “In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease,” Clinical and Experimental Immunology, vol. 129, no. 3, pp. 549–555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Leipe, M. Grunke, C. Dechant et al., “Role of Th17 cells in human autoimmune arthritis,” Arthritis and Rheumatism, vol. 62, no. 10, pp. 2876–2885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Lenarczyk, J. Helsloot, K. Farmer, L. Peters, A. Sturgess, and B. Kirkham, “Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls,” Clinical and Experimental Immunology, vol. 122, no. 1, pp. 41–48, 2000. View at Publisher · View at Google Scholar · View at Scopus